Targeting Stim and Orai Proteins as an Alternative Approach in Anticancer Therapy

E-ISSN： 1875-533x|23|30|3450-3480

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.30, 2016-10, pp. : 3450-3480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting IAPs as An Approach to Anti-Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 3, 2011-02 ,pp. : 291-316

Bentham Science Publishers

Access to resources Recommend Favorite

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-01 ,pp. : 1091-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Phosphatidylserine in Anti-Cancer Therapy

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2719-2723

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy

By Krasnov George S Dmitriev Alexey A Lakunina Valentina A Kirpiy Alexander A Kudryavtseva Anna V

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1221-1233

Informa Healthcare

Access to resources Recommend Favorite

Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-01 ,pp. : 675-689

Bentham Science Publishers

Access to resources Recommend Favorite